Latest publications for May 2022 from Cochrane Infectious Diseases Group
During May 2022, the CIDG published one new protocol, one new review and two updated reviews in Issue 5, 2022 of the Cochrane Database of Systematic Reviews,
New Protocol
- Korula P, Alexander H, John J, Kirubakaran R, Singh B, Tharyan P, Rupali P. Favipiravir for treating COVID‐19. Cochrane Database of Systematic Reviews 2022, Issue 5. Art. No.: CD015219. DOI: 10.1002/14651858.CD015219
New Review
- Pillay S, Steingart KR, Davies GR, Chaplin M, De Vos M, Schumacher SG, Warren R, Theron G. Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin. Cochrane Database of Systematic Reviews 2022, Issue 5. Art. No.: CD014841. DOI: 10.1002/14651858.CD014841.pub2.
Updated Reviews
- Ebrahimzadeh S, Islam N, Dawit H, Salameh J-P, Kazi S, Fabiano N, Treanor L, Absi M, Ahmad F, Rooprai P, Al Khalil A, Harper K, Kamra N, Leeflang MMG, Hooft L, van der Pol CB, Prager R, Hare SS, Dennie C, Spijker R, Deeks JJ, Dinnes J, Jenniskens K, Korevaar DA, Cohen JF, Van den Bruel A, Takwoingi Y, van de Wijgert J, Wang J, Pena E, Sabongui S, McInnes MDF. Thoracic imaging tests for the diagnosis of COVID‐19. Cochrane Database of Systematic Reviews 2022, Issue 5. Art. No.: CD013639. DOI: 10.1002/14651858.CD013639.pub5.
- StruyfT, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MMG, Spijker R, Hooft L, Emperador D, Domen J, Tans A, Janssens S, Wickramasinghe D, Lannoy V, Horn SR A, Van den Bruel A. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19. Cochrane Database of Systematic Reviews 2022, Issue 5. Art. No.: CD013665. DOI: 10.1002/14651858.CD013665.pub3.
Throughout 2022, we will continue to add publications to our CIDG and READ-It websites regularly. Do continue to check our websites for updates and follow us on Twitter.
The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. The CIDG is led by Professor Paul Garner (Co-ordinating Editor) and Deirdre Walshe (Managing Editor). Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the United Nations Sustainable Development Goals.